Cotellic

Summary

Cotellic is a pharmaceutical product^[1].

Key Facts

• Cotellic is credited with the discovery of Exelixis^[2].
• Cotellic's instance of is recorded as pharmaceutical product^[3].
• Cotellic's instance of is recorded as mixture^[4].
• Cotellic's manufacturer is recorded as Hoffmann-La Roche^[5].
• Cotellic's developer is recorded as Genentech^[6].
• Cotellic's RxNorm CUI is recorded as 1722371^[7].
• Cotellic's European Medicines Agency product number is recorded as EMEA/H/C/003960^[8].
• Cotellic's National Drug Code is recorded as 50242-717^[9].
• Cotellic's has active ingredient is recorded as cobimetinib^[10].
• Cotellic's therapeutic area is recorded as melanoma^[11].
• Cotellic's PBS Drug Code is recorded as 11074W^[12].

Body

Designation and Status

Recorded instance of include pharmaceutical product^[3] and mixture^[4].